Subcutaneous Drug Delivery Devices Market Outlook and Competitive Analysis with Key Players 2027

Felton, California , USA, Dec 21 2021 — /EPR Network/ — The “Subcutaneous Drug Delivery Devices Market” report gives a massive source to analyze the industry and other fundamental technicalities identifying with it. The examination discloses the total assessment and veritable parts of the Subcutaneous Drug Delivery Devices market. This study exhibits a straightforward outline of the industry, that integrates applications, blueprints, industry chain structure, and definitions. This report prepares a case for investments in different regions based on a practical view of their regulatory outline, manufacturing dynamics, and availability of skills and resources in that region.


The global subcutaneous drug delivery devices market size is anticipated to value USD 46.6 billion until 2027. It is also expected to register a CAGR of 10.4% over the forecasted years, 2020 to 2027. The need for reducing needle injuries and surging prevalence of self-administrative drug delivery is projected to propel the market growth.


Get Free PDF Sample (Including Full TOC, List of Tables & Figures) @


The pen injectors product segment dominated the global market due to the increasing number of product approvals, affordability and higher social acceptance. On the other hand, the wearable injectors segment is anticipated to register the highest CAGR in the upcoming years due to their feature of administrating higher-volume and viscosity biological drugs.


In 2019, the segment of retail pharmacies dominated the global market with a 44.9% share on account of increasing self-administration and rising patient awareness across this region. The online pharmacies segment accounted for the highest CAGR across the global market in the upcoming years on account of discounts and offers provided by the vendors over the online purchase.


North America accounted for the highest share of around 44.1% across the global subcutaneous drug delivery devices market in 2019 due to the increasing number of investments in the healthcare sector in the U.S. and Canada. The Asia Pacific is anticipated to register substantial growth in the upcoming years due to the rising number of diabetic patients across countries like India and China.


The market across the globe includes key players such as Ypsomed AG, Gerresheimer AG, Insulet Corporation, Unilife Corporation, PharmaJet, and Elcam Medical Group. Rapid technological developments and product innovations are undertaken by these players to gain a cutting edge over other players.


Know More Insights @


Matched content

Editor’s pick

Express Press Release Distribution